Candel Therapeutics CADL
NASDAQ CADL
$8.37 -0.27 (-3.13%)
At close: Oct 21, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Revenue (2020 - 2023)

Updated

Candel Therapeutics' Revenue was $31,000 in Q4 2022, unchanged from $31,000 a year earlier and unchanged from the prior quarter.

Analysis

Candel Therapeutics (CADL) Revenue (2020 - 2023) Analysis & Trends

For FY2022, Revenue at Candel Therapeutics came in at $125,000, unchanged from FY2021.

  • In earlier years, Revenue was $125,000 in FY2021 (unchanged) and $125,000 in FY2020.
  • Per Business Quant data, CADL's Revenue in the three quarters before Q4 2022 was $31,000 (Q3 2022), $31,000 (Q2 2022) and $31,000 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 Candel Therapeutics 620.85 Mn 111.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 102,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 31,000.00
Jun 30, 2022 31,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 31,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 31,000.00
Mar 31, 2021 31,000.00
Dec 31, 2020 31,000.00
Sep 30, 2020 31,000.00
Jun 30, 2020 31,000.00
API Access

Candel Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CADL&period=max&api_key=YOUR_API_KEY